Stanford University
Showing 2,761-2,780 of 13,032 Results
-
Krista Donaldson
Casual - Non-Exempt, School of Medicine - MDRP'S - Biodesign Program
Current Role at StanfordDirector of Innovation to Impact, Byers Center for Biodesign
-
Sarah S. Donaldson, MD
Catharine and Howard Avery Professor in the School of Medicine, Emerita
Current Research and Scholarly InterestsCombined Modality Treatment of Cancer
Late Effects of Treatment
Genetic Effects of Cancer
Rhabdomyosarcoma
Hodgkins Disease
Pediatric Radiation Oncolgy
Pediatric Oncolgy
Breast Cancer
Conformal Radiotherapy/IMRT
Radiotherapy for Benign Diseases -
Chunyang Dong
Postdoctoral Scholar, Psychiatry
BioChunyang Dong completed his Ph.D. studies from University of California, Davis with Dr. Lin Tian, where he specialized in protein engineering to develop genetically encoded biosensors to enable real-time imaging of neuromodulator dynamics. As part of his postdoctoral pursuits with Dr. Sergiu Pasca at Stanford University, he hopes to combine disciplines between biosensors and modeling human neurological disease using brain region-specific organoids. Despite this shift, his unwavering goal is to deepen the understanding of brain development, disease processes, and translate research to potential treatments for neurological disorders.
-
Fei Dong
Associate Professor of Pathology
BioDr. Dong is the Director of Molecular Pathology at Stanford Health Care. The Molecular Pathology laboratory offers a broad menu of clinical diagnostic tests ranging from PCR to next generation sequencing. Dr. Dong's academic interests include the clinical implementation of laboratory developed tests, the development of novel informatics algorithms, and characterization of disease by molecular methods. Before arriving at Stanford, Dr. Dong was on faculty at Brigham and Women’s Hospital/Harvard Medical School for nine years, where he established a track record in education and mentorship and was the recipient of both the Anatomic Pathology and Clinical Pathology resident teaching awards. Dr. Dong has served on committees for the Association for Molecular Pathology, the Clinical and Laboratory Standards Institute, and the United States and Canadian Academy of Pathology. He serves on the editorial boards of multiple scientific journals and is an Associate Editor for the Journal of Molecular Diagnostics.
-
Tobias Xiao Dong
Clinical Assistant Professor, Medicine
BioTobias Dong, MD, PhD, is a Clinical Assistant Professor in the Division of Hospital Medicine and Stanford School of Medicine. He obtained his MD/PhD from the University of California, Irvine, with his PhD thesis in Immunology. He then completed his Internal Medicine residency at the University of Southern California, before joining the Oncology Hospitalist program at Stanford in its inaugural year. His past research work has been in imaging calcium signaling dynamics in T cell function, in particular that of regulatory T cells, as well as the creation of a transgenic mouse model with a genetically encoded calcium indicator. His current interests include inpatient oncology care, cancer mortality, and medical education.
-
Joseph Donnelly, MD
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Donnelly is a board-certified orthopaedic surgeon with subspecialty board certification in orthopaedic sports medicine. He is the medical director of Sports Medicine and the vice chief of Orthopaedics for Stanford Health Care Tri-Valley. He is also a clinical assistant professor at Stanford University School of Medicine.
As a clinician, Dr. Donnelly delivers comprehensive prevention and treatment strategies for sports-related orthopaedic trauma. He specializes in the arthroscopic treatment of disorders of the shoulder and knee. He provides particular expertise in minimally invasive and tissue-sparing surgery such as all-inside ACL reconstruction and arthroscopic fixation of shoulder rotator cuff tears.
He has extensive experience providing game coverage and athletic trainer support for teams including the Oakland Athletics of Major League Baseball as well as high school and college teams. He also has made numerous presentations to educate the community regarding prevention, evaluation, and treatment of injuries in athletes. -
Igor D. Bandeira
Postdoctoral Scholar, Psychiatry
BioIgor D. Bandeira, M.D., Ph.D., is a Postdoctoral Research Fellow in the Department of Psychiatry and Behavioral Sciences at Stanford University. With extensive experience in interventional psychiatry, Dr. Bandeira has led multiple clinical trials focused on noninvasive brain stimulation and rapid-acting antidepressants for psychiatric disorders in children, adolescents, and adults. He received the prestigious Professor Alfredo Thomé de Britto Award in recognition of his exceptional research achievements during his physician-scientist training at the Federal University of Bahia in Salvador, Brazil.
As part of his medical training, Dr. Bandeira also studied at the University of Sydney (Australia) on a Science Without Borders Scholarship, where he enhanced his clinical and research skills at the university’s Brain and Mind Centre. Upon returning to Brazil, he gained valuable clinical experience as an attending physician with the Brazilian Ministry of Health and worked on the frontlines during the COVID-19 pandemic.
At Stanford, working with Dr. Nolan R. Williams, Dr. Bandeira led the Wellcome LEAP trial on accelerated intermittent theta-burst stimulation (Stanford Neuromodulation Therapy) to treat anhedonic depression. Alongside Dr. Alan F. Schatzberg, he is co-leading a trial supported by the American Foundation for Suicide Prevention, evaluating the efficacy and safety of buprenorphine in sustaining the antisuicidal effects of ketamine. His work centers on developing personalized therapeutics for treatment-resistant depression, bipolar depression, and suicidal behavior.
Looking ahead, Dr. Bandeira plans to apply for psychiatry residency programs in the United States to advance his career in academic psychiatry and clinical research.
